Durable SARS-CoV-2 B cell immunity after mild or severe disease is a research paper published in medRxiv (2020). On theSindex it has a DataRank of 0. It has been cited 21 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R01NR005228-03
LONGITUDINAL STUDY OF DEPRESSION IN LUNG CANCER
National Institutes of Health
Grant: 4U54CA260492-02
Johns Hopkins Excellence in Pathogenesis and Immunity Center for SARS-CoV-2 (JH-EPICS)
National Institutes of Health
Grant: 5R21AI151353-02
Development of a single-cell antibody cloning protocol for isolation of hepatitis C virus-specific broadly neutralizing antibodies
National Institutes of Health
Grant: 2R01AI127469-06A1
Molecular and structural characterization of broadly neutralizing anti-HCV antibodies
NCI NIH HHS
Grant: U54 CA260492
NIAID NIH HHS
Grant: R01 AI127469
NIAID NIH HHS
Grant: R21 AI151353
NINR NIH HHS
Grant: R01 NR005228
NIAID NIH HHS
Grant: HHSN272201400007C
Fields of Study
Keywords
Sustainable Development Goals